To investigate whether E1A expression alone, without contribution from additional viral genes and viral replication, could sensitize prostate cancer cells to the cytotoxic drugs, an expression plasmid was constructed encoding only the small E1A12S (ΔCR3) cDNA under control of the CMV promoter (Fig. 1A). The gene discussed is DHTKD1; the disease is prostate carcinoma.